Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunosuppression through HNF-1β signaling in human ovarian clear cell cancer ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Nishio, Hiroshi
- Beteiligte Personen und Organisationen
-
Sugiyama, Juri
Yaguchi, Tomonori
Aoki, Daisuke
Kawakami, Yutaka
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P168
- URN
-
urn:nbn:de:1111-2016072652347
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nishio, Hiroshi
- Sugiyama, Juri
- Yaguchi, Tomonori
- Aoki, Daisuke
- Kawakami, Yutaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
SOX17 expression in ovarian clear cell carcinoma
Immunosuppression
Chemical immunosuppression
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma
Napsin A as a marker of clear cell ovarian carcinoma
Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro
Hedgehog signaling pathway in ovarian cancer
Notch signaling in serous ovarian cancer
SOX17 expression in ovarian clear cell carcinoma
Immunosuppression
Chemical immunosuppression
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma
Napsin A as a marker of clear cell ovarian carcinoma
Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro
Hedgehog signaling pathway in ovarian cancer
Notch signaling in serous ovarian cancer
SOX17 expression in ovarian clear cell carcinoma
Immunosuppression
Chemical immunosuppression
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma
Napsin A as a marker of clear cell ovarian carcinoma
Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro
Hedgehog signaling pathway in ovarian cancer